CXCR2在肿瘤进展中的作用 |
| |
引用本文: | 陆柏江 江滨 皇甫少华. CXCR2在肿瘤进展中的作用[J]. 中国肿瘤外科杂志, 2021, 13(6): 615-618 |
| |
作者姓名: | 陆柏江 江滨 皇甫少华 |
| |
作者单位: | 1. 南京中医药大学2. 南京市中医院肛肠中心3. 南京中医药大学附属南京中医院 |
| |
基金项目: | 国家自然科学基金青年基金项目 |
| |
摘 要: | CXCR2与人体免疫关系密切,多项研究表明CXCR2及其配体在结肠癌、乳腺癌、肝癌、肾细胞癌、黑色素瘤、胰腺癌、卵巢癌等多种肿瘤细胞中呈高表达,在促进肿瘤生长、转移、血管生成等肿瘤进展过程中发挥重要作用。CXCR2在多种肿瘤的诊断以及预后的判断上具有重要价值。包括CXCR2拮抗剂SB225002在内的多种趋化因子拮抗剂在多项研究中都表现出了抑制血管生成及抑制肿瘤细胞生长、转移等作用。文章对CXCR2及其配体在肿瘤进展中的作用进行综述,为肿瘤的靶向治疗提供新的思路。
|
关 键 词: | 肿瘤 CXCR2 结肠癌 进展 作用 |
收稿时间: | 2021-03-10 |
修稿时间: | 2021-07-09 |
The role of CXCR2 in tumor progression |
| |
Abstract: | CXCR2 plays a wide role in malignant tumors and is closely related to the human immune system. Many studies have shown that CXCR2 and its ligands express highly in colon cancer, breast cancer, liver cancer, renal cell carcinoma, melanoma, pancreatic cancer, ovarian cancer and other tumor cells. CXCR2 and its ligands also play an important role in promoting tumor growth, metastasis, angiogenesis and other tumor progressions. Meanwhile, CXCR2 has been proved to be of great value in the diagnosis and prognosis of various kinds of tumors. Multiple chemokine antagonists, including CXCR2 antagonist SB225002, have shown inhibitory effects on angiogenesis, tumor cell growth and metastasis in several studies. This review focuses on the role of CXCR2 and its ligands in tumor progression, with our goals to provide new solutions for the optimization of targeted therapy and the future development of antineoplastic drugs. |
| |
Keywords: | |
|
| 点击此处可从《中国肿瘤外科杂志》浏览原始摘要信息 |
|
点击此处可从《中国肿瘤外科杂志》下载全文 |
|